Saltar al contenido principal
Soluciones
›
Ensayos descentralizados
›
Reclutamiento y selección
›
Monitorización remota de pacientes
›
Participación del paciente
›
Data Capture and Monitoring
›
ePRO + eCOA
›
Virtual Visits and Support
›
Analysis and Reporting
›
Regulatory and Security
Plataforma DCT
›
Obvio Go
›
ePro
›
Study Manager
›
Logística de ensayos
›
Consentimiento
›
Sensores y dispositivos portátiles
Industries
›
Consultoría DCT
›
Servicios CRO
›
Equipo del sitio virtual
›
Consumer Health
Acerca de nosotros
Recursos
›
Todos los recursos
›
Careers
Resources
›
All Resources
›
Blog
›
Press Releases
›
Events
›
Playbooks
›
White Papers
›
Case Studies
›
Videos
.botón.luz primaria
.botón.rosa primario
© 2020 La calificación de Obvio Health USA, Inc.
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

No items found.
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

No items found.
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

No items found.
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

No items found.
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Download the PDF
No items found.

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Back to Top
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.

Discover More Case Studies

Discover More News

Discover More White Papers

Discover More Blogs

Discover More Playbooks

Discover More Webinars

Discover More Events

Infectious Disease

Norovirus Vaccine Study​

VaxArt needed solutions for evaluating the safety and immunogenicity of its orally administered norovirus vaccine. Of particular importance was incorporating a way to quickly detect severe reactogenicity symptoms during the first week following vaccine administration. ​

› Read More
CNS

Treatment-Resistant Depression Study 

A global pharmaceutical company needed to understand the impact of a dissociative anesthetic on quality of life in patients with treatment-resistant depression. The company sought a way to gather high-quality data and carefully monitor suicidality. 

› Read More